Downregulation of GLYAT correlates with tumour progression and poor prognosis in hepatocellular carcinoma

Documenti analoghi

• STRN3 promotes tumour growth in hepatocellular carcinoma by inhibiting the hippo pathway
  di: Jie Zhu, et al.
  Pubblicazione: (2024)
• Multifaceted role of FAM210B in hepatocellular carcinoma: Implications for tumour progression, microenvironment modulation and therapeutic selection
  di: Xianzhu Pan, et al.
  Pubblicazione: (2024)
• EDNRA regulates the tumour immune environment and predicts the efficacy and prognosis of cancer immunotherapy
  di: Mengxue Wang, et al.
  Pubblicazione: (2024)
• Overexpression of malic enzyme is involved in breast cancer growth and is correlated with poor prognosis
  di: Wan‐Chung Hu, et al.
  Pubblicazione: (2024)
• Comprehensively analysis of IL33 in hepatocellular carcinoma prognosis, immune microenvironment and biological role
  di: Lifang Wei, et al.
  Pubblicazione: (2024)